Coverage & Payment

AdvaMed submitted a response to a U.S. House of Representatives Healthy Futures Task Force, Subcommittee on Treatments (Subcommittee on Treatments) Request for Information (RFI) on information to help foster patient…

AdvaMed submitted a letter to the Centers for Medicare and Medicaid Services (CMS) regarding coverage and payment policies for skin substitute products as used and paid for in the outpatient…

In advance of CMS’ release of the proposed End-Stage Renal Disease (ESRD) Prospective Payment System (PPS) rule, AdvaMed submitted a letter focused on coverage and payment policies for ESRD patients.

AdvaMed submitted comments on the Centers for Medicare and Medicaid Services’ Advance Notice of Methodological Changes for Calendar Year 2023 for Medicare Advantage Capitation Rate and Part C and Part…

AdvaMed submitted a response to a U.S. House of Representatives Healthy Futures Task Force, Modernization Subcommittee (the Modernization Subcommittee) Request for Information (RFI) on the utilization of wearable technologies, expansion…

AdvaMed submitted a letter to the Centers for Medicare and Medicaid Services (CMS) regarding coverage and payment policies addressed under the Physician Fee Schedule (PFS) in anticipation of upcoming Calendar…

In advance of annual rulemaking, AdvaMed submitted a letter to the Centers for Medicare and Medicaid Services (CMS) regarding coverage and payment policies addressed under the Hospital Outpatient Prospective Payment…

In advance of annual rulemaking, AdvaMed submitted a letter to the Centers for Medicare and Medicaid Services (CMS) regarding coverage and payment policies addressed under the Hospital Inpatient Prospective Payment…

AdvaMed submitted a response to a Centers for Medicare and Medicaid Services (CMS) Request for Information (RFI) on potential changes to the requirements transplant programs, organ procurement organizations, and end-stage…